Monday, 1 April 2019

Novartis pays $310 million upfront for inflammation specialist IFM

Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker seeks to expand its immunology pipeline.


from Reuters: Business News https://ift.tt/2HR4ibc

No comments:

Post a Comment

America's homebuilding is powered by immigrant workers. Here are the places that rely on them the most.

The cities building the most homes rely more heavily on immigrant labor. Allen J. Schaben / Los Angeles Times The cities that build and...